We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we ...

Merck must face trial on a Black IT director’s claims that racial bias drove his firing after he ordered the removal of a White contractor from a project, a New York federal judge ruled.

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

The first week of President Donald Trump’s second term included several executive orders and actions that will be detrimental ...

Merck and Japan-based Eisai said on Friday a combination of their therapies failed to extend the lives of patients with a ...

The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious ...

Even if Robert F. Kennedy Jr. is confirmed as the next Health and Human Services secretary, he still plans to collect fees ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

During the call, company executives will provide an overview of Merck’s performance for the fourth quarter and outlook for 2025. Investors, journalists and the general public may access a live ...

Berenberg Bank analyst Luisa Hector maintained a Buy rating on Merck & Company (MRK – Research Report) yesterday and set a price target of $125.00. The company’s shares closed yesterday at $99.65.

According to Davis, "the breadth and the depth" of Merck's current pipeline is the most diversified in the company's recent history, with its portfolio is broadening into the cardiometabolic space ...